Ingrid Abrahamsen

Executive Director, Head of Clinical Operations

Fulcrum Therapeutics

Brian Alexander, MD, MPH

CEO

Valo Health

Kevin Anderson

Former Sr. Director, Clinical Operations, Therapeutics

Christopher Arendt

Chief Science Officer, Head of Research

Takeda

Mark Arquiza

Associate Director, Clinical Monitoring Oversight

Apellis Pharmaceuticals

Ashley Avery

Senior Specialist, Quality Documents & Archival

AbbVie

Carla Bauer

Director, Oncology Search and Evaluation, Business Development & Licensing

Merck

Daniel Beal

Director, Clinical Program Lead

Mediar Therapeutics

Wendy Beeby

Former Head, Clinical Trial Associates

Takeda

Bruce Beutel

CEO and Cofounder

Passkey

Jess Birardi

Senior Influencer Marketing Strategist 

Syneos Health Communications

Eric Blanchard

Partner

Cooley LLP

Irene Blat

Head of External Innovation, North America

Servier

Paul Bolno

President & CEO

Wave Life Sciences

Gadi Bornstein

Senior Director, External Innovation

Johnson & Johnson Innovative Medicine

Ben Bradford

Head of External Affairs

MassBio

Carolyn Britten, MD

VP, Clinical Development, Solid Tumors,

BeOne

Gabriel Brooks

Chief Medical Officer

Solid Biosciences

Jared Brooslin

Senior Manager, Trial Master File

Intellia Therapeutics

Karim Budhwani

CEO-Scientist

CerFlux

Stephen Bychowski

General Counsel, Assistant General Counsel BD&L Pharma

Sanofi Ventures

Scott Cenci

SVP, Chief Information & Data Officer

Acadia Pharmaceuticals

Priya Chaturvedi

VP,  Head of Global Clinical Quality

Eisai

Kleem Chaudhary

Chief Executive Officer

Hyku Biosciences

Hyelim Cho

VP, Head of Strategy

Actithera

Ryan Clements

Practice Area Lead, Consulting

Syneos

Anu Connor

Vice President, Head of Oncology Search and Evaluation

Ipsen

Katie Conover

EVP, Corporate Affairs

Syneos Health Communications

Helena Cowley

Director, Global Alliance Management

Takeda

Joe Daley

President

Addison Whitney

Anne de Schweinitz

Head, Global Corporate Brand & Content

Takeda

Ann DeWitt

Siegrid Delgadillo

Director, eTMF services

Premier Research

Scott Dewire

Corporate Senior Vice President & Head of Global Business Development

Boehringer Ingelheim

Elena Diez Cecilia, PhD, MBA

Senior Director, External Innovation, DPDS

Janssen R&D

Valentina Dilda

Former Director of Clinical Innovation and Transformation

Cerevel/AbbVie

Eric Dimise

Director, Healthcare & Life Sciences, Capital Markets

New York Stock Exchange

Susan Edelstein

SVP, Clinical Research

Ardelyx

Wendy Erler

Senior Vice President Patient Affairs

Sarepta Therapeutics

Debbie Etchison

Executive Director, Head of Corporate Affairs

Alkeus Pharmaceuticals

Mike Exton

CEO and Board Director

Lexicon Pharmaceuticals, Inc.

Stephanie Fagan

Chief Corporate Affairs Officer

Definium Therapeutics

Melina Fan

Co-founder & Chief Innovation Officer

Addgene

Liz Farrell

Director, Compliance and TMF Oversight

Agios Pharmaceuticals

Adam Feire

Head of Business Development and New Ventures

Biogen

Rosalie Filling

Vice President & Senior Global Head of R&D Strategy, Innovation & Operations

Keenova Therapeutics

Susan Fitzpatrick-Napier

CEO

TrialWire

Tori Fort

SVP, Corporate Strategy and Corporate Affairs

Ovid Therapeutics

Kristen Fortney, PhD

Co-Founder & CEO

BioAge Labs

Diana Gallagher, MD

SVP, Head of Clinical Development for MS, Immunology and Alzheimer's

Biogen

Sarah Ganley

Associate Director of Standards & Processes

Arrowhead Pharmaceuticals

Chris Ganter

Associate Director, Global Quality Compliance

Vertex Pharmaceuticals

Harry Georgiades

Managing Director

IPM

Alice Gilman

Founder & COO

R3 Bio

Kelly Gold

CFO

CAMP4 Therapeutics

Sherry Goldberg

U.S. Chief Executive Officer and Global Chief Operating Officer

GCI Health

Rob Goldstein-Mahon

Executive Director, Patient Advocacy

Ionis Pharmaceuticals

Colleen Graham

SVP, Clinical Operations

Mediar Therapeutics

Abigail Gregor

Partner, Life Sciences Licensing & Collaborations

Ropes & Gray

Joseph Grieco

VP of Clinical Development

Tris Pharma

Rahul Gupta

President

GATC Health

John Gustofson

Head

Chugai Venture Fund

Daniel Haders II, PhD

Co-Founder & CEO

Model Medicines

Sue Hager

Advisory Partner

Andreessen Horowitz

Eason Hahm

Director, BioPharma

William Blair

Rebecca Halbur

Associate Director, TMF Records Mangement, Cinical Trial Systems & Operations

Moderna

Catherine Hall

Head of GXP Quality Assurance

Egnyte

Wael Harb

Head of R&D and Scientific Strategy, Early Phase Oncology

Syneos Health

Nick Hargaden

Sr. Director, TMF

Merus B.V.

Jamie Harrop

Vice President Clinical Operations

Beam Therapeutics

Roger Heerman

Chief Business/Operating Officer / Co-founder

Kinaset Therapeutics

Sheela Hegde

Managing Partner & Global Head

Health Advances

Karin Hellsvik

Vice President, Corporate Affairs, Investor Relations and Operations

Foghorn Therapeutics

Echo Hindle-Yang

Founder and Chief Executive Officer

MSQ Ventures

Mary Jane Hinrichs

Senior Vice President, Early Development,

Ipsen

Narimon Honarpour, MD, PhD

Senior Vice President, Global Development

Amgen

Christelle Huguet

Executive Vice President, Head of R&D

Ipsen

Darren Incorvaia

Staff Writer

Fierce Biotech

Allison Intondi

VP, Clinical Operations

Coherus Oncology

Cynthia Isaac

Group Managing Director, Corporate Affairs

Syneos Health Communications

Christiana Iyasere

MD, MBA, Senior Director Technology Business Development and Accelerator

Dana-Farber Cancer Institute

Anthony Jarkowski

Senior Vice President, Primary Focus Lead, Head of Immuno-Oncology

Astellas Pharma

Padmini Jayaraman

Business Development Executive

Alphanumeric Systems

Michael Jones

Search & Evaluation Lead, GI & Inflammation,

Takeda

Jose Juves

Chief Corporate & Patient Affairs Officer

Dyne Therapeutics

Nandini Kashyap

Conference Director,

Fierce Life Sciences

Ariel Katz

CEO and Co-founder

H1

Abbas Kazimi

Chief Executive Officer

Nimbus Therapeutics

Adam Keeney

Executive Vice President and Head of Corporate Development

Biogen

Jared Kelly

CEO

Oncolytics Biotech

Ryan Kelly

Chief Communications Officer

Recursion

Matthew Kennedy

AVP, Neuroscience and Neuroimmunology Lead

Merck

Prarthana Khanna PhD

Vice President, Head of Corporate Business Development and Strategy

Vico Therapeutics

Peter Kilford, PhD

Associate Vice President, Global Sales

Simulations Plus

Jessica Kirshner

Vice President of Oncology and Immuno-Oncology

Regeneron

James Kirwin

COO & SVP Clinical Development

SFA Therapeutics

Jenelle Krishnamoorthy

Senior Vice President and Head of Global Policy & Public Affairs

Merck & Co.

John Lacey

Lead, Corporate R&D and Science Communications

Takeda

Andrew Lam

Managing Director, Head of Biotech Private Equity

Ally Bridge Group

Carla Lema Tomé

Vice President, Global Business Development

Otsuka

Rita Lemming

Director, Clinical Operations

Fulcrum Therapeutics

Lizabeth Leveille

Vice President, BD&L and Head, Boston Innovation Hub & Discovery Transactions

Merck

Michael Levey

Director, Global Media Relations

Merck

Stacy Lindborg, PhD

President, Chief Executive Officer & Board Director

IMUNON, Inc.

Alex Loboda

Director, Clinical Quality

Korro Bio

Hobson Lopes

Associate Director, Records and Archive Management

Regeneron

Carlos Lopez-Espina

SVP, Research and Development

Prenosis

Maria Maccecchini

CEO

Annovis

Katya Maganova

Managing Director, Consulting

Syenos

John Maraganore, PhD

Founding and Co-CEO,

Corsera Health, Alnylam Pharmaceuticals; CEO and Principal, JMM Innovations

Megan Mason

Implementation Manager, Global Process Development

Lonza

Jennifer McCafferty, PhD,

Senior Vice President, Head of CMC-Regulatory and MRL Quality Assurance,

Merck

Theresa McNeely

Chief Communications Officer

Lifordi Immunotherapeutics, Inc.

Rachel Mercado

Principal, AI Consulting, Clinical AI & Technology Innovation

IQVIA

Jennifer Michaelson, Ph.D.

Chief Scientific Officer

Cullinan Therapeutics

Liza Micioni

Sr. Director, Head of Clinical Operations

Tris Pharma, Inc.

Brian Miglionico

Vice President, Business Development

Agios Pharmaceuticals

Mayank Misra

Vice President, Global Commercial Strategy, Analytics, & Ops

Soleno Therapeutics, Inc

Emilijia Mitrikeska

Associate Director, Business Development

University of Michigan Medical School | Rogel Cancer Center

Amber Monaghan

Director

IPM

Ahmed Mousa

Chief Executive Officer

Vicore Pharma

Curran Murphy

Senior Director Clinical Operations / Head of Clinical Business Operations

Blueprint Medicines

John Murray

VP Global Business Development & Country Head UK

SanaClis

Nikhil Mutyal

Head of Search and Evaluation - Respiratory & Immunology

AstraZeneca

Miki Nakamori

Executive Director, Head of Scouting & Transaction, PFGR/BR, Business Development

Astellas Pharma Inc.

Tatiana Novobrantseva, PhD

Chief Scientific Officer

NextPoint Therapeutics

Kate O'Malley

Vice President, Corporate Affairs

Moderna

Emily Oldshue

Partner

Ropes & Gray

Eric Olson

Chief Business Officer & Executive Vice President

Ultragenyx

Kendra Orjada

Sr. Director, Clinical Research Policy

Merck

Jacob Petersen

Senior Vice President, Global Research in Research and Development

Novo Nordisk

Alexander Pickett

Managing Director

Juvenescence

Daniele Piergentili

Chairman and CEO

Fabbrica Italiana Sintetici S.p.A. (F.I.S)

Thomas Potgieter

Senior Vice President, Cell Therapy Development and Operations

Bristol Myers Squibb

Raviv Pryluk

CEO & Co Founder

PhaseV

Suguna Rachakonda

Vice President, Business Development and Licensing (US)

Insilico Medicine

Bhaskar Rege, PhD

Senior Vice President, Pharmaceutical and Early-Stage Development

Alkermes

Michael Reilly

Chief Strategy Officer

Varda Space Industries

Gene Rhie

US Head of Immunology

UCB

Kristen Riemenschneider

Head of US Life Sciences

Freshfields

Courtney Ronaldo

Associate Vice President, Global and U.S. Human Health and Manufacturing Communications

Merck

Kendra Rose

Senior Vice President, BD&L

Bayer

Shana Ross

Senior Manager, TMF Quality Oversight 

Moderna

Martine Rothblatt

Founder, Chairperson, and CEO

United Therapeutics

Mark Rutter

VP, Regulatory Affairs

Formation Bio

Anup Sabharwal

Vice President, Head of R&D and Scientific Strategy in Cardiovascular, Renal, and Metabolic Medicine

Syneos Health

Dennis Salotti

Sr. Director & Head, Strategic Outsourcing & Clinical Innovation

Jazz Pharmaceuticals

Amber Salzman, Ph.D.

Chief Executive Officer

Epicrispr Biotechnologies

Frédéric Scaerou

Head of Global Business Development

Servier

Marc Schwabish

Chief Business Officer

Tectonic Therapeutic

Evan Seigerman

Managing Director, Head of Healthcare Research BioPharma & Biotechnology

BMO Capital Markets

David Setboun

CEO

PharmatrophiX

Wei Shao

Director, Business Development and Strategy

Alexion Pharmaceuticals

Madeleine Shin

Executive Director, Global Head of External Communications and Media

Biogen

Kelly Simpliciano

Sr. Director, Audit & Inspection Management

BioNTech US

Chris Slavinsky

Former General Counsel and Head of Compliance

Corstasis Therapeutics

David Soergel, MD

Chief Medical Officer

Madrigal

Erik Sokolowski

Sr. Director, Clinical Operations

Zevra Therapeutics

Tracy Sorrentino

Vice President, Corporate Affairs

Sarepta Therapeutics

Aleksandra Stankovic

Founding Director of the Center for Space Medicine Research

Massachusetts General Hospital and Harvard Medical School

Rob Staszewski

Associate Director, Clinical Oversight & Systems

United Therapeutics

Dietrich Stephan

Chief Executive Officer, Chairman of the Board, and Co-Founder

Seyltx

Uli Stilz

Senior Advisor

Flagship Pioneering

Sriram Subramanian

Chief Executive Officer

Ferma

Joseph Szustakowski

Vice President of Clinical Development Data Science and AI

Genmab

Claris Tsang Munksgaard

Director, Global Business Development and Licensing

EMD Serono, Inc

Peter Tummino

President of Research & Development

Nimbus Therapeutics

Markus Vallaster, MD, PhD

Global Medical Head, Oncology Early Development & Hemato-Oncology,

Astellas Pharma

Steph Viscomi

Director, Clinical Documentation & TMF

Apellis Pharmaceuticals

Thomas Von Erlach

Co-Founder, Chief Executive Officer

Vivitex

James Waldron

Senior Editor

Fierce Biotech

Neil Warma

CEO

ProMIS Neurosciences

John Wehrli

Shareholder

Greenberg Traurig

John Wichelt

VP of Operations and Site Director

Kindeva Bridgeton

Jane Williams

Vice President, Medical Management

Syneos Health

Juliet Williams, PhD

Head of Research

Kymera

Vanessa Wolfeler

CEO

SERB Pharma

Sandeep Yadav, Ph.D.

VP, Technical Development

Sangamo Therapeutics

Don Yeung

Sr. Director, Head of Global Clinical Drug Supply

Genmab